Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Medoz Pharmacy of Polk Inc
WARNING LETTER
•Medoz Pharmacy of Polk Inc•August 9, 2019

Medoz Pharmacy of Polk Inc – FDA Warning Letter, Aug 9, 2019

Record Details

On September 25, 2020, the FDA issued a Warning Letter to Medoz Pharmacy of Polk Inc. following an inspection from July 30 to August 9, 2019. The inspection revealed serious deficiencies in the production of sterile drug products, rendering them adulterated under Section 501(a)(2)(A) of the FDCA due to insanitary conditions.

Observed violations included: - Presence of vermin (dead ants, living spiders, dead cockroach) in the cleanroom, anteroom, and non-sterile suite. - Inadequate containment, segregation, and cleaning for hazardous drug products, risking cross-contamination. - Visibly dirty equipment and surfaces, including blue stains on an ISO 5 work surface during aseptic production. - Cracks in the cleanroom flooring. - Improper gowning procedures by personnel, including bare hand exposure in the ISO 5 area. - Manual contact with inner surfaces of sterile stoppers during aseptic production. - Stained HEPA filters, gaps, and chipping paint around HEPA frames in cleanrooms. - Failure to use a sporicidal agent in ISO 5 areas. - Inadequate smoke studies under dynamic conditions to demonstrate unidirectional airflow in the ISO 5 area.

The firm stated it ceased sterile compounding and voluntarily relinquished its Florida Department of Health sterile compounding permit effective August 2, 2019. The FDA recommends

Company
Medoz Pharmacy of Polk Inc
Inspection date
August 9, 2019
Product type
Drugs
Office
Office of Pharmaceutical Quality Operations Division I
Person
  • Monica R. Maxwell (Program Division Director)
View Company Profile

ID · 661b99be-7fea-478e-903d-da905f0d3a32

Violation Codes6
21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 351(a)(2)(A)21 U.S.C. 331(k)21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Other documents for Medoz Pharmacy of Polk Inc
  • 483 - 2021-08-27August 27, 2021
  • 483 - 2019-08-09August 9, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Medoz Pharmacy of Polk Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.